S. Maekawa

发表

Stratifying the risk of lymph node metastasis in undifferentiated-type early gastric cancer.

N. Enomoto, M. Kurosaki, M. Sakamoto, 2015, World journal of gastroenterology.

Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice

N. Enomoto, H. Fujii, R. Katoh, 2017, Pancreas.

Deep Sequencing of Cancer-Related Genes Revealed GNAS Mutations to Be Associated with Intraductal Papillary Mucinous Neoplasms and Its Main Pancreatic Duct Dilation

N. Enomoto, S. Maekawa, M. Fukasawa, 2014, PloS one.

Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated‐interferon plus ribavirin therapy for chronic hepatitis C

N. Enomoto, M. Kurosaki, M. Sakamoto, 2013, Journal of medical virology.

Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.

N. Enomoto, M. Kurosaki, S. Kakinuma, 2004, The Journal of infectious diseases.

Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma

N. Enomoto, M. Sakamoto, K. Moriishi, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Deep Sequencing and Phylogenetic Analysis of Variants Resistant to Interferon-Based Protease Inhibitor Therapy in Chronic Hepatitis Induced by Genotype 1b Hepatitis C Virus

N. Enomoto, M. Sakamoto, K. Moriishi, 2015, Journal of Virology.

Deep sequencing analysis of variants resistant to the non‐structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection

N. Enomoto, M. Sakamoto, S. Maekawa, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Serum RANTES level influences the response to pegylated interferon and ribavirin therapy in chronic hepatitis C

N. Enomoto, M. Sakamoto, K. Moriishi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Comprehensive analysis for viral elements and interleukin‐28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection

N. Enomoto, M. Sakamoto, T. Kitamura, 2012, Hepatology.

Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C

N. Enomoto, M. Sakamoto, T. Kitamura, 2011, Hepatology International.

Analysis of the Complete Open Reading Frame of Genotype 2b Hepatitis C Virus in Association with the Response to Peginterferon and Ribavirin Therapy

N. Enomoto, M. Sakamoto, N. Sakamoto, 2011, PloS one.

Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapy

N. Enomoto, M. Sakamoto, N. Sakamoto, 2011, Hepatology international.

Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients

N. Enomoto, M. Honda, S. Kaneko, 2012, Hepatology International.

HCV Genetic Elements Determining the Early Response to Peginterferon and Ribavirin Therapy

N. Enomoto, S. Maekawa, 2010, Intervirology.

Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon‐alpha plus ribavirin combination therapy

N. Enomoto, M. Kurosaki, S. Kakinuma, 2005, Journal of gastroenterology and hepatology.

Genetic changes in the interferon sensitivity determining region of hepatitis C virus during the natural course of chronic hepatitis C

N. Enomoto, M. Kurosaki, F. Marumo, 2000, Journal of medical virology.

Usefulness of Cell‐Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy

N. Enomoto, K. Yamauchi, S. Maekawa, 2021, Hepatology communications.

Cancer‐related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings

N. Enomoto, M. Matsuda, K. Moriishi, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins.

N. Enomoto, S. Kakinuma, N. Sakamoto, 2005, Gastroenterology.

Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm

U. Motosugi, S. Ichikawa, N. Enomoto, 2019, Medicine.

Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress

N. Enomoto, K. Moriishi, S. Maekawa, 2017, Antiviral research.

Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study

N. Enomoto, H. Kono, S. Maekawa, 2021, BMC Cancer.

Liver stiffness measurement for risk assessment of hepatocellular carcinoma

N. Enomoto, M. Sakamoto, S. Maekawa, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide

N. Enomoto, A. Ryo, Y. Matsuura, 2015, Scientific Reports.

Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features

N. Enomoto, M. Sakamoto, S. Kakinuma, 2016, Journal of Gastroenterology.

Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy

N. Enomoto, M. Kurosaki, N. Izumi, 2015, PloS one.

Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

H. Nomura, H. Yoshiji, N. Enomoto, 2014, Human Genetics.

Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary mucinous neoplasm of the pancreas

N. Enomoto, D. Ichikawa, T. Kondo, 2019, Journal of gastroenterology.

Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication

N. Enomoto, N. Sakamoto, M. Nakagawa, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing

N. Enomoto, D. Ichikawa, T. Kondo, 2021, International journal of molecular sciences.

Targeting lipid metabolism in the treatment of hepatitis C virus infection.

N. Enomoto, M. Sakamoto, N. Sakamoto, 2008, The Journal of infectious diseases.

/T-Thalassemia with Hemochromatosis

F. Marumo, S. Maekawa, Y. Miyahara, 2006 .

Involvement of FKBP6 in hepatitis C virus replication

N. Enomoto, M. Matsuda, H. Fujii, 2015, Scientific Reports.

Deep-Sequencing Analysis of the Association between the Quasispecies Nature of the Hepatitis C Virus Core Region and Disease Progression

N. Enomoto, M. Sakamoto, K. Moriishi, 2013, Journal of Virology.

Inhibitory Effects of Caffeic Acid Phenethyl Ester Derivatives on Replication of Hepatitis C Virus

N. Enomoto, N. Sakamoto, N. Kato, 2013, PloS one.

Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication.

M. Kurimoto, S. Kakinuma, N. Sakamoto, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Carcinoembryonic antigen levels in pancreatic juice are associated with histological subtypes of intraductal papillary mucinous neoplasm of the pancreas

N. Enomoto, K. Mochizuki, H. Kono, 2022, DEN open.

Griseofulvin, an oral antifungal agent, suppresses hepatitis C virus replication in vitro

N. Enomoto, N. Sakamoto, Haofan Jin, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Correlation between pretreatment viral sequences and the emergence of lamivudine resistance in hepatitis B virus infection

N. Enomoto, M. Sakamoto, S. Maekawa, 2012, Journal of medical virology.

Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay

N. Enomoto, A. Setiawan, M. Baba, 2015, Marine drugs.

Efficacy of endoscopic clipping for bleeding gastroduodenal ulcer: comparison with topical ethanol injection

I. Sakuma, S. Maekawa, C. Sato, 1999, American Journal of Gastroenterology.

Specific inhibition of hepatitis C virus replication by cyclosporin A.

N. Enomoto, M. Kurosaki, S. Kakinuma, 2004, Biochemical and biophysical research communications.

Expressional screening of interferon‐stimulated genes for antiviral activity against hepatitis C virus replication

N. Enomoto, M. Kurosaki, S. Kakinuma, 2006, Journal of viral hepatitis.

Hallmarks of Hepatitis C Virus in Equine Hepacivirus

N. Enomoto, K. Ochiai, M. Morimatsu, 2014, Journal of Virology.

A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors.

Masahiko Ito, Daisuke Takaya, Hideaki Umeyama, 2011, Bioorganic & Medicinal Chemistry.

Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity

N. Enomoto, A. Ryo, K. Moriishi, 2017, Antiviral research.

Complemental Diagnosis of IgG4-Related Pancreaticobiliary Diseases by Multiple Hypoechoic Lesions in the Submandibular Glands

N. Enomoto, S. Maekawa, M. Fukasawa, 2022, Journal of clinical medicine.

HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers

N. Enomoto, M. Sakamoto, K. Moriishi, 2019, PloS one.

Viral Variation and Response to Therapy

N. Enomoto, S. Maekawa, 2016 .

Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C

N. Enomoto, S. Maekawa, 2009, Journal of Gastroenterology.

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.

N. Enomoto, M. Honda, S. Kaneko, 2011, Journal of hepatology.

Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C

N. Enomoto, S. Maekawa, 2013, Journal of Gastroenterology.

Genetic alterations related to endoscopic treatment of colorectal tumors

N. Enomoto, K. Mochizuki, S. Maekawa, 2019, JGH open : an open access journal of gastroenterology and hepatology.

Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factor-alpha-mediated apoptosis in Huh7 cells.

N. Enomoto, M. Kurosaki, N. Sakamoto, 2003, The Journal of infectious diseases.

Inhibition of intracellular hepatitis C virus replication by synthetic and vector‐derived small interfering RNAs

Mamoru Watanabe, Kazunari Taira, Li Yi, 2003, EMBO reports.

Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA

M. Yano, N. Enomoto, N. Sakamoto, 2007, Journal of gastroenterology and hepatology.

Regulation of Hepatitis C Virus Replication by Interferon Regulatory Factor 1

N. Enomoto, M. Kurosaki, S. Kakinuma, 2004, Journal of Virology.

Digital next‐generation sequencing of cell‐free DNA for pancreatic cancer

N. Enomoto, S. Maekawa, M. Fukasawa, 2021, JGH open : an open access journal of gastroenterology and hepatology.

DICKKOPF‐4 and ‐2 genes are upregulated in human colorectal cancer

Shinichi Takano, Akira Matsui, Masahiko Otaka, 2009, Cancer science.

Next‐generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer

N. Enomoto, S. Maekawa, M. Fukasawa, 2021, Cancer science.

Alterations in Cancer-related Genes Associated with Grading of Well Differentiated Pancreatic Neuroendocrine Neoplasms

N. Enomoto, H. Fujii, K. Mochizuki, 2017 .

Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver

N. Enomoto, M. Kurosaki, N. Sakamoto, 1995, Journal of medical virology.

Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma

N. Enomoto, S. Maekawa, M. Kadokura, 2020, Scientific Reports.

Usefulness of Circulating CYFRA21-1 in Patients as a Biomarker in Patients Taking Sorafenib or Lenvatinib for Unresectable Hepatocellular Carcinoma

N. Enomoto, S. Maekawa, M. Fukasawa, 2021, Reports.

Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia

N. Enomoto, S. Tsuneda, N. Sakamoto, 2012, Marine drugs.

Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C

N. Enomoto, M. Sakamoto, M. Nakagawa, 2018, Journal of Gastroenterology.

Detection of Antiviral Drug-Resistant Variants in Chronic Hepatitis C by Deep Sequencing

N. Enomoto, S. Maekawa, Mitsuaki Sato, 2017 .

The “real-world” efficacy and safety of DAAs for the treatment of HCV patients throughout Japan

N. Enomoto, S. Maekawa, 2018, Journal of Gastroenterology.

Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma

N. Enomoto, M. Sakamoto, S. Maekawa, 2015, Mediators of inflammation.

Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response.

N. Enomoto, N. Sakamoto, M. Nakagawa, 2007, The Journal of general virology.

Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3

N. Enomoto, M. Kurosaki, N. Sakamoto, 2006, Journal of Gastroenterology.

Fractionated small cell‐free DNA increases possibility to detect cancer‐related gene mutations in advanced colorectal cancer

N. Enomoto, D. Ichikawa, S. Maekawa, 2020, JGH open : an open access journal of gastroenterology and hepatology.

Form-Vessel Classification of Cholangioscopy Findings to Diagnose Biliary Tract Carcinoma’s Superficial Spread

N. Enomoto, S. Maekawa, M. Fukasawa, 2020, International journal of molecular sciences.

Role of magnifying endoscopy with narrow‐band imaging in the diagnosis of noninvasive gastric neoplasia

N. Enomoto, K. Mochizuki, Yukiko Asakawa, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Deep sequencing analysis of serum hepatitis B virus‐RNA during nucleot(s)ide analogue therapy

N. Enomoto, K. Moriishi, S. Maekawa, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

T cell receptor-mediated signaling induces GRP78 expression in T cells: the implications in maintaining T cell viability.

N. Enomoto, A. Nakao, M. Kitamura, 2008, Biochemical and biophysical research communications.

Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer.

N. Enomoto, D. Ichikawa, K. Mochizuki, 2019, Pancreas.

Enhancement of mitochondrial gene expression in the liver of primary biliary cirrhosis.

N. Enomoto, M. Kurosaki, S. Kakinuma, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Inhibition of Both Protease and Helicase Activities of Hepatitis C Virus NS3 by an Ethyl Acetate Extract of Marine Sponge Amphimedon sp

N. Enomoto, S. Tsuneda, N. Sakamoto, 2012, PloS one.

Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma

N. Enomoto, S. Maekawa, M. Fukasawa, 2022, Oncology.

Hepatocellular carcinoma risk assessment using gadoxetic acid‐enhanced hepatocyte phase magnetic resonance imaging

U. Motosugi, T. Ichikawa, N. Enomoto, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical significance of genetic alterations in endoscopically obtained pancreatic cancer specimens

N. Enomoto, S. Maekawa, M. Fukasawa, 2021, Cancer medicine.

Spontaneous portosystemic shunt diameter predicts liver function after balloon‐occluded retrograde transvenous obliteration

N. Enomoto, H. Onishi, S. Maekawa, 2022, JGH Open.

HBV patients with low HBsAg and high HBcrAg titers have a high risk of HBV‐related HCC

N. Enomoto, M. Sakamoto, K. Moriishi, 2018 .

Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma

N. Enomoto, S. Maekawa, M. Kadokura, 2020, Scientific Reports.

Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography

M. Yin, U. Motosugi, N. Enomoto, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment

N. Enomoto, S. Maekawa, Y. Nakayama, 2022, Internal medicine.

Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

H. Nomura, H. Yoshiji, N. Enomoto, 2015, Human Genetics.

Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing

N. Enomoto, K. Mochizuki, Yukiko Asakawa, 2019, Gastric Cancer.

[Interferon resistance and ISDR (interferon sensitivity determining region)].

N. Enomoto, S. Maekawa, F. Amemiya, 2006, Nihon rinsho. Japanese journal of clinical medicine.

Dickkopf‐4 gene expression is associated with differentiation and lymph node metastasis in colorectal cancer

N. Enomoto, S. Maekawa, Tatsuya Yamaguchi, 2019, JGH open : an open access journal of gastroenterology and hepatology.

Analysis of direct‐acting antiviral‐resistant hepatitis C virus haplotype diversity by single‐molecule and long‐read sequencing

N. Enomoto, K. Yamauchi, S. Maekawa, 2022, Hepatology communications.

Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma‐like area and metachronous hepatocellular carcinoma

N. Enomoto, S. Kakinuma, M. Nakagawa, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Effect of a combination of pemafibrate and a mild low‐carbohydrate diet on obese and non‐obese patients with metabolic‐associated fatty liver disease

H. Morisaka, N. Enomoto, H. Onishi, 2023, Journal of gastroenterology and hepatology.

Site‐specific mutation of the interferon sensitivity‐determining region (ISDR) modulates hepatitis C virus replication

N Enomoto, N. Enomoto, M. Kurosaki, 2006, Journal of viral hepatitis.

Transjugular intrahepatic portosystemic shunt for severe ascites in a patient with cirrhosis and on chronic hemodialysis-a case report

I. Sakuma, S. Maekawa, C. Sato, 1997 .

Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.

N. Enomoto, M. Kurosaki, N. Izumi, 1999, Virology.

Hepatic Amyloidosis with an Extremely High Stiffness Value on Magnetic Resonance Elastography

U. Motosugi, N. Enomoto, M. Sakamoto, 2016, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response.

N. Enomoto, N. Sakamoto, M. Nakagawa, 2007, The Journal of general virology.

Assessment of lower limb muscle strength can predict fall risk in patients with chronic liver disease

S. Maekawa, Mitsuaki Sato, S. Takano, 2024, Scientific reports.

Significance of the autoantibody assay in predicting the development of immune‐related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma

S. Maekawa, Mitsuaki Sato, S. Takano, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.

Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment.

S. Maekawa, S. Takano, Nobuyuki Enomoto, 2024, Journal of the Formosan Medical Association = Taiwan yi zhi.

Target sequencing of cancer-related genes in early esophageal squamous neoplasia resected by endoscopic resection in Japanese patients

N. Enomoto, M. Sakamoto, Yukiko Asakawa, 2018, Oncotarget.

IL‐28B (IFN‐λ3) and IFN‐α synergistically inhibit HCV replication

N. Enomoto, M. Sakamoto, K. Moriishi, 2013, Journal of viral hepatitis.

Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma

N. Enomoto, S. Maekawa, Mitsuaki Sato, 2023, Oncology.